Physicians’ Education Resource® (PER®), a leading resource for continuing medical education (CME), will present an interactive live video webcast entitled Virtual Tumor Board® titled “Diagnosis and Management of Polycythemia Vera and Myelofibrosis” Thursday, Feb. 21, at 8 p.m. EST.
CRANBURY, N.J.--(BUSINESS WIRE)-- Physicians’ Education Resource® (PER®), a leading resource for continuing medical education (CME), will present an interactive live video webcast entitled Virtual Tumor Board® titled “Diagnosis and Management of Polycythemia Vera and Myelofibrosis” Thursday, Feb. 21, at 8 p.m. EST. The tumor board will be chaired by Ronald Hoffman, M.D., Albert A. and Vera G. List professor of medicine, hematology and medical oncology and director of the myeloproliferative disorders research program at Icahn School of Medicine at Mount Sinai.
“We are excited to present this new CME-certified ‘virtual’ activity that incorporates real-world case scenarios of patients with myeloproliferative neoplasms (MPNs),” said Phil Talamo, president of PER®. “Attendees who participate in the webcast will gain expert insights into new treatments for myelofibrosis and polycythemia vera, and how to leverage evidence-based treatment strategies in specific clinical situations across MPNs.”
During this live CME-certified educational webcast, Hoffman, along with faculty expert Gillian Sanchez, MPH, BSN, RN, clinical research program manager for the adult leukemia program at the Icahn School of Medicine, will explore trends in the prognostic scoring, molecular diagnostic studies and appropriate guideline-based management of MPNs, as well as current and emerging therapeutic strategies across MPNs.
This live webcast is accredited by the Accreditation Council for Continuing Medical Education for 1.5 AMA PRA Category 1 Credits™ for physicians. For more information and to register, click here.
About Physicians’ Education Resource®
Since 1995, PER® has been dedicated to advancing cancer care through professional education and now furthers patient care and treatment strategies on a wide variety of chronic illnesses and diseases. In 2016, PER® initiated CME programming in the cardiovascular and endocrinology areas. While continuing to expand into topics outside of oncology, PER® remains the leading provider of live, online and print CME activities related to oncology and hematology. The high-quality, evidence-based activities feature leading distinguished experts who focus on the application of practice-changing advances. PER® is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER® is part of the Cranbury, New Jersey-based MJH Associates Inc. family of businesses. Learn more at http://www.gotoper.com and http://www.mjhassoc.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190211005648/en/
Contacts
PER® Media
Alexandra Ventura, 609-716-7777, ext. 121
aventura@mjhassoc.com
John Patricolo, 609-325-4630
jpatricolo@mjhassoc.com
Source: Physicians’ Education Resource